CS227018B2 - Method of preparing cycloaliphatic ketoamines - Google Patents

Method of preparing cycloaliphatic ketoamines Download PDF

Info

Publication number
CS227018B2
CS227018B2 CS818317A CS831781A CS227018B2 CS 227018 B2 CS227018 B2 CS 227018B2 CS 818317 A CS818317 A CS 818317A CS 831781 A CS831781 A CS 831781A CS 227018 B2 CS227018 B2 CS 227018B2
Authority
CS
Czechoslovakia
Prior art keywords
acid
formula
carbon atoms
compound
bis
Prior art date
Application number
CS818317A
Other languages
Czech (cs)
English (en)
Inventor
Jurgen Dr Engel
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of CS227018B2 publication Critical patent/CS227018B2/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C27/00Processes involving the simultaneous production of more than one class of oxygen-containing compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS818317A 1980-11-17 1981-11-12 Method of preparing cycloaliphatic ketoamines CS227018B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3043350 1980-11-17

Publications (1)

Publication Number Publication Date
CS227018B2 true CS227018B2 (en) 1984-04-16

Family

ID=6116998

Family Applications (1)

Application Number Title Priority Date Filing Date
CS818317A CS227018B2 (en) 1980-11-17 1981-11-12 Method of preparing cycloaliphatic ketoamines

Country Status (17)

Country Link
AT (1) AT379379B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1187489A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS227018B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD202285A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK507581A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EG (1) EG15343A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8206441A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI77649C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2087397A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR76339B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU185671B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE52081B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU83751A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX7032E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO152294C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT73979B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU42253B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0211254A3 (de) * 1985-07-31 1988-05-04 ASTA Pharma Aktiengesellschaft Neue cycloaliphatische Ketoamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI70205C (fi) * 1978-05-17 1986-09-15 Degussa Foerfarande foer framstaellning av nya terapeutiskt anvaendbara l-/3-hydroxi-3-fenylpropyl-(2)/-/3-oxo-propyl/aminer

Also Published As

Publication number Publication date
NO152294B (no) 1985-05-28
ES507158A0 (es) 1982-08-16
PT73979A (de) 1981-12-01
NO152294C (no) 1985-09-04
IE812677L (en) 1982-05-17
MX7032E (es) 1987-03-03
LU83751A1 (de) 1982-02-18
ES8206441A1 (es) 1982-08-16
FI77649C (fi) 1989-04-10
IE52081B1 (en) 1987-06-10
PT73979B (de) 1983-04-26
AT379379B (de) 1985-12-27
GR76339B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-08-04
NO813881L (no) 1982-05-18
CA1187489A (en) 1985-05-21
DK507581A (da) 1982-05-18
FI77649B (fi) 1988-12-30
YU42253B (en) 1988-06-30
EG15343A (en) 1986-09-30
FI813623L (fi) 1982-05-18
GB2087397A (en) 1982-05-26
YU269081A (en) 1983-09-30
ATA493281A (de) 1985-05-15
DD202285A5 (de) 1983-09-07
HU185671B (en) 1985-03-28

Similar Documents

Publication Publication Date Title
US6001836A (en) Dihydropyridine NPY antagonists: cyanoguanidine derivatives
RU2096411C1 (ru) Производные бензимидазолона, смеси их изомеров или их кислотно-аддитивные соли в качестве антагониста рецептора 5-ht*00i*00a и 5-нт*002
AU701420B2 (en) Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them
Turner et al. Studies on imidazole compounds. I. 4-Methylimidazole and related compounds
US5994356A (en) Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
US20020173512A1 (en) Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
US5696123A (en) Neurokinin antagonists
CS197300B2 (en) Method of producing new 1-/isoquinoline-1-one-2-yl and 1,2,3,4-tetrahydrobenzazepine-1-one-2-ylalkyl/ phenyl-et
FI62052B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 4-aminofenyletanolaminer med saerskilt beta 2-mimetisk och/eller alfa 1-blockerande verkan
CA1061357A (en) Phenylalkylamines
FI66373B (fi) Foerfarande foer framstaellning av farmakologiskt verksamma n-xacyklyl-alkyl-piperidiner
FI58325C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla sulfamider
JPH0794417B2 (ja) N−アミノブチル−n−フェニルアリールアミド誘導体
US5708006A (en) Neurokinin antagonists
US4973592A (en) 1,3-diazocycloalkenes as muscarinic receptor blocking agents
CS227018B2 (en) Method of preparing cycloaliphatic ketoamines
GB2142021A (en) 1 4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them
DK163055B (da) Analogifremgangsmaade til fremstilling af 2-dipropylamino-(5 eller 7)-formylamino-6-hydroxy-1,2,3,4-tetrahydronaphthalen og farmakologisk acceptable syreadditionssalte deraf
HU185432B (en) Process for producing indene derivatives
CA3179538A1 (en) Preparation of a 1,3,5-triazinyl benzimidazole
JPS6153281A (ja) 1,3−置換−2−イミダゾリジノン誘導体,胃腸運動亢進剤及びその製造方法
FI61694C (fi) Foerfarande foer framstaellning av substituerade arylalkylaminer med blodtrycket och hjaertslagfrekvensen saenkande verkan
KR800001287B1 (ko) 치환된 아릴알킬 아민의 제조방법
US3153039A (en) Bicyclic aminoketones and method for the production thereof
US4000313A (en) 1-Isopropylamino-3[4'-(2-methoxy- or ethoxy-carbonylaminoethoxy)-phenoxy]propanol-2 and cardioselective antagonism use